Pfizer statement on U.S. FDA approval of Over-the-Counter Nexium

31-03-2014 Business Wire HealthComments (0)

PfizerPharmaceutical

Today the U.S. Food and Drug Administration (FDA) approved over-the-counter Nexium® 24HR (esomeprazole 20mg) marking a key step towards providing those who suffer from frequent heartburn broader access to a brand doctors and patients have trusted for years. In 2012, Pfizer acquired exclusive global rights from AstraZeneca to market non-prescription Nexium®. The addition of Nexium® 24HR to the Pfizer Consumer Healthcare portfolio expands the breadth of categories in wh

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top